Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Synopsis
The mechanism of action of aluminum adjuvant mainly includes storage effect and immunostimulatory effect. Aluminum adjuvant can also stimulate innate immunity and induce monocytes to secrete IL-1β and IL-18 by activating Nlrp3 inflammasome. In addition, aluminum adjuvant can stimulate necrotic cells at the injection site to release damage-associated pattern molecules (DAMPs) such as DNA, ATP, and uric acid, and the released DAMPs help the interaction between dendritic cells and CD4+ T cells.
Global Aluminum Adjuvanted Vaccines market is projected to reach US$ 1210.5 million in 2029, increasing from US$ 650 million in 2022, with the CAGR of 9.3% during the period of 2023 to 2029. Influencing issues, such as economy environments, COVID-19 and Russia-Ukraine War, have led to great market fluctuations in the past few years and are considered comprehensively in the whole Aluminum Adjuvanted Vaccines market research.
Vaccination programs are essential for the prevention of infectious diseases, and aluminum adjuvanted vaccines play an important role in many immunization programs. Rising awareness regarding the importance of vaccination and expanding vaccination programs across the globe is boosting the demand for aluminum adjuvanted vaccines.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2023-2029), aims to help readers to get a comprehensive understanding of global Aluminum Adjuvanted Vaccines market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
By Company
Segment by Type
Segment by Application
Consumption by Region
The Aluminum Adjuvanted Vaccines report covers below items:
Chapter 1: Product Basic Information (Definition, Type and Application)
Chapter 2: Manufacturers’ Competition Patterns
Chapter 3: Country Level Sales Analysis
Chapter 4: Product Type Analysis
Chapter 5: Product Application Analysis
Chapter 6: Manufacturers’ Outline
Chapter 7: Industry Chain, Market Channel and Customer Analysis
Chapter 8: Market Opportunities and Challenges
Chapter 9: Market Conclusions
Chapter 10: Research Methodology and Data Source
Index
1 Aluminum Adjuvanted Vaccines Market Overview
1.1 Product Overview and Scope of Aluminum Adjuvanted Vaccines
1.2 Aluminum Adjuvanted Vaccines Segment by Type
1.2.1 Global Aluminum Adjuvanted Vaccines Market Value Comparison by Type (2023-2029)
1.2.2 Aluminum Phosphate
1.2.3 Aluminum Hydroxide
1.2.4 Potassium Aluminum Sulfate
1.3 Aluminum Adjuvanted Vaccines Segment by Application
1.3.1 Global Aluminum Adjuvanted Vaccines Market Value by Application: (2023-2029)
1.3.2 Hospital
1.3.3 Clinic
1.4 Global Aluminum Adjuvanted Vaccines Market Size Estimates and Forecasts
1.4.1 Global Aluminum Adjuvanted Vaccines Revenue 2018-2029
1.4.2 Global Aluminum Adjuvanted Vaccines Sales 2018-2029
1.4.3 Global Aluminum Adjuvanted Vaccines Market Average Price (2018-2029)
1.5 Assumptions and Limitations
2 Aluminum Adjuvanted Vaccines Market Competition by Manufacturers
2.1 Global Aluminum Adjuvanted Vaccines Sales Market Share by Manufacturers (2018-2023)
2.2 Global Aluminum Adjuvanted Vaccines Revenue Market Share by Manufacturers (2018-2023)
2.3 Global Aluminum Adjuvanted Vaccines Average Price by Manufacturers (2018-2023)
2.4 Global Aluminum Adjuvanted Vaccines Industry Ranking 2021 VS 2022 VS 2023
2.5 Global Key Manufacturers of Aluminum Adjuvanted Vaccines, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Aluminum Adjuvanted Vaccines, Product Type & Application
2.7 Aluminum Adjuvanted Vaccines Market Competitive Situation and Trends
2.7.1 Aluminum Adjuvanted Vaccines Market Concentration Rate
2.7.2 The Global Top 5 and Top 10 Largest Aluminum Adjuvanted Vaccines Players Market Share by Revenue
2.7.3 Global Aluminum Adjuvanted Vaccines Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.8 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Aluminum Adjuvanted Vaccines Retrospective Market Scenario by Region
3.1 Global Aluminum Adjuvanted Vaccines Market Size by Region: 2018 Versus 2022 Versus 2029
3.2 Global Aluminum Adjuvanted Vaccines Global Aluminum Adjuvanted Vaccines Sales by Region: 2018-2029
3.2.1 Global Aluminum Adjuvanted Vaccines Sales by Region: 2018-2023
3.2.2 Global Aluminum Adjuvanted Vaccines Sales by Region: 2024-2029
3.3 Global Aluminum Adjuvanted Vaccines Global Aluminum Adjuvanted Vaccines Revenue by Region: 2018-2029
3.3.1 Global Aluminum Adjuvanted Vaccines Revenue by Region: 2018-2023
3.3.2 Global Aluminum Adjuvanted Vaccines Revenue by Region: 2024-2029
3.4 North America Aluminum Adjuvanted Vaccines Market Facts & Figures by Country
3.4.1 North America Aluminum Adjuvanted Vaccines Market Size by Country: 2018 VS 2022 VS 2029
3.4.2 North America Aluminum Adjuvanted Vaccines Sales by Country (2018-2029)
3.4.3 North America Aluminum Adjuvanted Vaccines Revenue by Country (2018-2029)
3.4.4 United States
3.4.5 Canada
3.5 Europe Aluminum Adjuvanted Vaccines Market Facts & Figures by Country
3.5.1 Europe Aluminum Adjuvanted Vaccines Market Size by Country: 2018 VS 2022 VS 2029
3.5.2 Europe Aluminum Adjuvanted Vaccines Sales by Country (2018-2029)
3.5.3 Europe Aluminum Adjuvanted Vaccines Revenue by Country (2018-2029)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Aluminum Adjuvanted Vaccines Market Facts & Figures by Country
3.6.1 Asia Pacific Aluminum Adjuvanted Vaccines Market Size by Country: 2018 VS 2022 VS 2029
3.6.2 Asia Pacific Aluminum Adjuvanted Vaccines Sales by Country (2018-2029)
3.6.3 Asia Pacific Aluminum Adjuvanted Vaccines Revenue by Country (2018-2029)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Southeast Asia
3.7 Latin America Aluminum Adjuvanted Vaccines Market Facts & Figures by Country
3.7.1 Latin America Aluminum Adjuvanted Vaccines Market Size by Country: 2018 VS 2022 VS 2029
3.7.2 Latin America Aluminum Adjuvanted Vaccines Sales by Country (2018-2029)
3.7.3 Latin America Aluminum Adjuvanted Vaccines Revenue by Country (2018-2029)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.7.7 Colombia
3.8 Middle East and Africa Aluminum Adjuvanted Vaccines Market Facts & Figures by Country
3.8.1 Middle East and Africa Aluminum Adjuvanted Vaccines Market Size by Country: 2018 VS 2022 VS 2029
3.8.2 Middle East and Africa Aluminum Adjuvanted Vaccines Sales by Country (2018-2029)
3.8.3 Middle East and Africa Aluminum Adjuvanted Vaccines Revenue by Country (2018-2029)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Aluminum Adjuvanted Vaccines Sales by Type (2018-2029)
4.1.1 Global Aluminum Adjuvanted Vaccines Sales by Type (2018-2023)
4.1.2 Global Aluminum Adjuvanted Vaccines Sales by Type (2024-2029)
4.1.3 Global Aluminum Adjuvanted Vaccines Sales Market Share by Type (2018-2029)
4.2 Global Aluminum Adjuvanted Vaccines Revenue by Type (2018-2029)
4.2.1 Global Aluminum Adjuvanted Vaccines Revenue by Type (2018-2023)
4.2.2 Global Aluminum Adjuvanted Vaccines Revenue by Type (2024-2029)
4.2.3 Global Aluminum Adjuvanted Vaccines Revenue Market Share by Type (2018-2029)
4.3 Global Aluminum Adjuvanted Vaccines Price by Type (2018-2029)
5 Segment by Application
5.1 Global Aluminum Adjuvanted Vaccines Sales by Application (2018-2029)
5.1.1 Global Aluminum Adjuvanted Vaccines Sales by Application (2018-2023)
5.1.2 Global Aluminum Adjuvanted Vaccines Sales by Application (2024-2029)
5.1.3 Global Aluminum Adjuvanted Vaccines Sales Market Share by Application (2018-2029)
5.2 Global Aluminum Adjuvanted Vaccines Revenue by Application (2018-2029)
5.2.1 Global Aluminum Adjuvanted Vaccines Revenue by Application (2018-2023)
5.2.2 Global Aluminum Adjuvanted Vaccines Revenue by Application (2024-2029)
5.2.3 Global Aluminum Adjuvanted Vaccines Revenue Market Share by Application (2018-2029)
5.3 Global Aluminum Adjuvanted Vaccines Price by Application (2018-2029)
6 Key Companies Profiled
6.1 Emergent BioSolutions
6.1.1 Emergent BioSolutions Corporation Information
6.1.2 Emergent BioSolutions Description and Business Overview
6.1.3 Emergent BioSolutions Aluminum Adjuvanted Vaccines Sales, Revenue and Gross Margin (2018-2023)
6.1.4 Emergent BioSolutions Aluminum Adjuvanted Vaccines Product Portfolio
6.1.5 Emergent BioSolutions Recent Developments/Updates
6.2 Sanofi
6.2.1 Sanofi Corporation Information
6.2.2 Sanofi Description and Business Overview
6.2.3 Sanofi Aluminum Adjuvanted Vaccines Sales, Revenue and Gross Margin (2018-2023)
6.2.4 Sanofi Aluminum Adjuvanted Vaccines Product Portfolio
6.2.5 Sanofi Recent Developments/Updates
6.3 GlaxoSmithKline Biologicals
6.3.1 GlaxoSmithKline Biologicals Corporation Information
6.3.2 GlaxoSmithKline Biologicals Description and Business Overview
6.3.3 GlaxoSmithKline Biologicals Aluminum Adjuvanted Vaccines Sales, Revenue and Gross Margin (2018-2023)
6.3.4 GlaxoSmithKline Biologicals Aluminum Adjuvanted Vaccines Product Portfolio
6.3.5 GlaxoSmithKline Biologicals Recent Developments/Updates
6.4 Pfizer
6.4.1 Pfizer Corporation Information
6.4.2 Pfizer Description and Business Overview
6.4.3 Pfizer Aluminum Adjuvanted Vaccines Sales, Revenue and Gross Margin (2018-2023)
6.4.4 Pfizer Aluminum Adjuvanted Vaccines Product Portfolio
6.4.5 Pfizer Recent Developments/Updates
6.5 Merck
6.5.1 Merck Corporation Information
6.5.2 Merck Description and Business Overview
6.5.3 Merck Aluminum Adjuvanted Vaccines Sales, Revenue and Gross Margin (2018-2023)
6.5.4 Merck Aluminum Adjuvanted Vaccines Product Portfolio
6.5.5 Merck Recent Developments/Updates
6.6 Wyeth Pharmaceuticals
6.6.1 Wyeth Pharmaceuticals Corporation Information
6.6.2 Wyeth Pharmaceuticals Description and Business Overview
6.6.3 Wyeth Pharmaceuticals Aluminum Adjuvanted Vaccines Sales, Revenue and Gross Margin (2018-2023)
6.6.4 Wyeth Pharmaceuticals Aluminum Adjuvanted Vaccines Product Portfolio
6.6.5 Wyeth Pharmaceuticals Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Aluminum Adjuvanted Vaccines Industry Chain Analysis
7.2 Aluminum Adjuvanted Vaccines Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Aluminum Adjuvanted Vaccines Production Mode & Process
7.4 Aluminum Adjuvanted Vaccines Sales and Marketing
7.4.1 Aluminum Adjuvanted Vaccines Sales Channels
7.4.2 Aluminum Adjuvanted Vaccines Distributors
7.5 Aluminum Adjuvanted Vaccines Customers
8 Aluminum Adjuvanted Vaccines Market Dynamics
8.1 Aluminum Adjuvanted Vaccines Industry Trends
8.2 Aluminum Adjuvanted Vaccines Market Drivers
8.3 Aluminum Adjuvanted Vaccines Market Challenges
8.4 Aluminum Adjuvanted Vaccines Market Restraints
9 Research Finding and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
Published By : QY Research